December 18, 2014

“New patent guidelines should be welcomed by pharma, life-science sector,” Inside Counsel, December 18, 2014

Inside Counsel
View Link

New, clearer interim guidelines recently were released by the United States Patent and Trademark Office (USPTO) on what subjects are eligible for patents.

The guidance replaces the more controversial guidelines that were released in March and helps explain on what subject matter applicants can get patents.

“It’s good news for the biopharma industry,” Leanne Rakers, an attorney with Harness Dickey, told InsideCounsel, adding that the December guidelines take a “less aggressive position” than those issued in March.

Read full article.